ViewRay Inc.

4.69-0.0700-1.47%Vol 607.70K1Y Perf 16.38%
Feb 3rd, 2023 16:00 DELAYED
BID4.65 ASK4.73
Open4.69 Previous Close4.76
Pre-Market- After-Market4.65
 - -  -0.04 -0.85%
Target Price
7.14 
Analyst Rating
Strong Buy 1.29
Potential %
52.24 
Finscreener Ranking
★★+     47.37
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★+     43.03
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
     38.31
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
89.49 
Earnings Rating
Strong Sell
Market Cap850.84M 
Earnings Date
27th Feb 2023
Alpha-0.00 Standard Deviation0.21
Beta1.10 

Today's Price Range

4.644.78

52W Range

2.394.96

5 Year PE Ratio Range

-5.10-4.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
3.76%
1 Month
9.84%
3 Months
6.11%
6 Months
42.12%
1 Year
16.38%
3 Years
50.32%
5 Years
-45.78%
10 Years
-

TickerPriceChg.Chg.%
VRAY4.69-0.0700-1.47
AAPL154.503.68002.44
GOOG105.22-3.5800-3.29
MSFT258.35-6.2550-2.36
XOM111.920.77000.69
WFC47.580.35000.74
JNJ164.61-0.9300-0.56
FB196.640.99000.51
GE81.96-1.9800-2.36
JPM141.092.15001.55
 
ProfitabilityValueIndustryS&P 500US Markets
6.20
-116.90
-111.10
-153.10
-
RevenueValueIndustryS&P 500US Markets
67.52M
0.37
-4.81
22.61
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.14-0.140.00
Q02 2022-0.15-0.150.00
Q01 2022-0.16-0.1412.50
Q04 2021-0.15-0.16-6.67
Q03 2021-0.16-0.156.25
Q02 2021-0.16-0.19-18.75
Q01 2021-0.16-0.17-6.25
Q04 2020-0.17-0.18-5.88
Earnings Per EndEstimateRevision %Trend
12/2022 QR-0.15-15.38Negative
12/2022 FY-0.59-3.51Negative
3/2023 QR-0.140.00-
12/2023 FY-0.56-12.00Negative
Next Report Date27th Feb 2023
Estimated EPS Next Report-0.16
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume607.70K
Shares Outstanding181.42K
Shares Float153.45M
Trades Count5.34K
Dollar Volume2.86M
Avg. Volume946.43K
Avg. Weekly Volume976.23K
Avg. Monthly Volume1.08M
Avg. Quarterly Volume778.18K

ViewRay Inc. (NASDAQ: VRAY) stock closed at 4.69 per share at the end of the most recent trading day (a -1.47% change compared to the prior day closing price) with a volume of 607.70K shares and market capitalization of 850.84M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 309 people. ViewRay Inc. CEO is Scott W. Drake.

The one-year performance of ViewRay Inc. stock is 16.38%, while year-to-date (YTD) performance is 4.69%. VRAY stock has a five-year performance of -45.78%. Its 52-week range is between 2.39 and 4.96, which gives VRAY stock a 52-week price range ratio of 89.49%

ViewRay Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 8.28, a price-to-sale (PS) ratio of 12.39, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -44.36%, a ROC of -57.81% and a ROE of -104.49%. The company’s profit margin is -%, its EBITDA margin is -111.10%, and its revenue ttm is $67.52 Million , which makes it $0.37 revenue per share.

Of the last four earnings reports from ViewRay Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.16 for the next earnings report. ViewRay Inc.’s next earnings report date is 27th Feb 2023.

The consensus rating of Wall Street analysts for ViewRay Inc. is Strong Buy (1.29), with a target price of $7.14, which is +52.24% compared to the current price. The earnings rating for ViewRay Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ViewRay Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ViewRay Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.71, ATR14 : 0.20, CCI20 : 49.86, Chaikin Money Flow : 0.16, MACD : 0.03, Money Flow Index : 55.47, ROC : 0.64, RSI : 53.79, STOCH (14,3) : 59.00, STOCH RSI : 0.77, UO : 50.31, Williams %R : -41.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ViewRay Inc. in the last 12-months were: B. Kristine Johnson (Buy at a value of $112 704), Brian K. Roberts (Buy at a value of $47 680), Caley Castelein (Buy at a value of $3 601 119), Daniel Jeffrey Moore (Buy at a value of $250 001), Karen N. Prange (Buy at a value of $100 002), Scott W. Drake (Buy at a value of $399 994), Susan C. Schnabel (Buy at a value of $300 930), Zachary William Stassen (Buy at a value of $318 250)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (14.29 %)
1 (14.29 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.29
Strong Buy
1.29
Strong Buy
1.33

ViewRay Inc.

ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, Monte Carlo treatment planning system, etc. The company holds license for its combination of MRI and radiation therapy technologies.

CEO: Scott W. Drake

Telephone: +1 440 703-3210

Address: 2 Thermo Fisher Way, Oakwood Village 44146, OH, US

Number of employees: 309

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

55%45%

TipRanks News for VRAY

Thu, 05 Jan 2023 13:50 GMT Analysts Offer Insights on Healthcare Companies: Viewray (VRAY) and IN8bio (INAB)

- TipRanks. All rights reserved.

Wed, 07 Sep 2022 11:55 GMT Viewray (VRAY) Receives a Buy from BTIG

- TipRanks. All rights reserved.

News

Stocktwits